Global Cell Line Development Serum Market Report 2020-2027: Fetal Bovine Serum Segment to Grow at a Fast Pace
Dublin, Jan. 27, 2021 (GLOBE NEWSWIRE) — The “Cell Line Development Serum Market Forecast to 2027 – COVID-19 Impact and Global Analysis by Type; By Application; and Geography” report has been added to ResearchAndMarkets.com’s offering.
Fetal Bovine Serum Segment to Grow at Fast Pace during 2020-2027.
The market is expected to reach US$ 1,467.92 million by 2027 from US$ 915.58 million in 2019; it is estimated to grow at a CAGR of 6.1% from 2020 to 2027.
The report provides trends prevailing in the global cell line development serum market, and the drivers and hindrances pertaining to the market growth.
Based on type, the global cell line development serum market is segmented into fetal bovine serum, adult bovine serum, porcine serum, horse serum, other animal serum. Fetal bovine serum segment held the largest share of the market in 2019 and is expected to register the highest CAGR of the market